Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[New perspectives on paracetamol].

Laurie F Prescott1

  • 1Pharmacologie Clinique, Université d'Edimbourg, Edimbourg, Ecosse, GB.

Drugs
|February 5, 2004
PubMed
Summary
This summary is machine-generated.

Paracetamol (acetaminophen) is a key pain reliever and fever reducer. Future research focuses on new formulations for faster or longer action, improved rectal dosage forms, and understanding its therapeutic mechanisms and potential antioxidant uses.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fifty years of paracetamol (acetaminophen) poisoning: the development of risk assessment and treatment 1973-2023 with particular focus on contributions published from Edinburgh and Denver.

Clinical toxicology (Philadelphia, Pa.)·2024
Same author

Paracetamol (acetaminophen) poisoning: The early years.

British journal of clinical pharmacology·2023
Same journal

The Long Road to Long-Acting: What Oral PrEP and CAB-LA Teach Us About Scaling Lenacapavir.

Drugs·2026
Same journal

Botulinum Toxin Type A for Trigeminal and Postherpetic Neuralgia: An Umbrella Review of Systematic Reviews.

Drugs·2026
Same journal

Biologics and Small Molecule Inhibitors: Novel Therapeutic Strategies for Cutaneous Adverse Drug Reactions.

Drugs·2026
Same journal

Use of Sedative-Hypnotic Drugs and the Risk of Developing Alzheimer's Disease: A Systematic Review, Meta-Analysis and Meta-Regression.

Drugs·2026
Same journal

Relacorilant: First Approval.

Drugs·2026
Same journal

Developmental Progress and Future Potential for Inhaled Biologics in the Treatment of Respiratory Diseases.

Drugs·2026
See all related articles

Area of Science:

  • Pharmacology
  • Toxicology
  • Drug Development

Background:

  • Paracetamol (acetaminophen) is a widely used over-the-counter antipyretic and analgesic.
  • Current research explores new formulations for enhanced absorption and extended duration of action.
  • Intravenous paracetamol use is expanding, particularly in postoperative care and intensive settings.

Purpose of the Study:

  • To review current and future developments in paracetamol formulations and therapeutic applications.
  • To discuss the mechanisms of paracetamol-induced liver toxicity and potential preventative strategies.
  • To explore novel therapeutic uses, such as antioxidant properties.

Main Methods:

  • Literature review of existing and emerging research on paracetamol.

Related Experiment Videos

  • Analysis of clinical applications and toxicological data.
  • Exploration of molecular mechanisms of action and toxicity.

    • Main Results:

    • Development of new paracetamol formulations for rapid and prolonged absorption is anticipated.
    • Intravenous paracetamol offers expanded clinical utility, with wider future availability expected.
    • Ongoing research into hepatotoxicity mechanisms aims to prevent liver failure in overdose cases.

    Conclusions:

    • Paracetamol's therapeutic applications are likely to broaden with further research into its mechanisms and novel formulations.
    • Addressing paracetamol toxicity remains a critical area, with advancements in understanding and treatment.
    • Potential antioxidant roles in preventing cardiovascular disease and cataracts warrant further investigation.